selenium disulfide has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, B; Huo, J; Su, Q; Tang, W; Xu, R; Yang, T; Zhan, Y; Zhang, D; Zhang, Y; Zhu, M | 1 |
| Huff, J | 1 |
2 other study(ies) available for selenium disulfide and Liver Neoplasms
| Article | Year |
|---|---|
Selenium sulfide disrupts the PLAGL2/C-MET/STAT3-induced resistance against mitochondrial apoptosis in hepatocellular carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Humans; Liver; Liver Neoplasms; Male; Mice; Mice, Nude; Mitochondria; Proto-Oncogene Proteins c-met; RNA-Binding Proteins; Selenium Compounds; Signal Transduction; STAT3 Transcription Factor; Transcription Factors | 2021 |
Re: Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Animals; Anticarcinogenic Agents; Antioxidants; DNA Damage; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Rats; Rats, Inbred Strains; Selenium Compounds; Skin Neoplasms; Testicular Neoplasms; Vitamin E | 2004 |